Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05029882
Title Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors AbbVie
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | AUS

Additional content available in CKB BOOST